This drug, which many in the medical community are heralding as "innovative," acts directly on the brain, offering new hope for countless women who are unable to undergo hormone replacement therapy.
If all goes well, this medication may become accessible by the year's end.
From Daily Mail UK:
Earlier this month the US approved fezolinetant, which is the first non-hormonal menopause drug.
Its makers describe it as a therapy 'based on our understanding of the biology behind hot flashes'.
The drug works by blocking a brain protein called neurokinin 3, that plays a role in regulating body temperature in menopausal women.
A large trial published this year showed that 12 weeks of taking the pill once a day reduced the frequency of hot flushes by about 60 per cent in women with moderate or severe symptoms, compared with a 45 per cent drop in those on a placebo.
Women also reported a reduction in the severity of hot flushes and better quality of sleep.
'This is going to be a completely blockbuster drug,' Professor Waljit Dhillo, an endocrinologist at Imperial College London, said.
'It's like a switch. Within a day or two the flushes go away – it's unbelievable how well these drugs work.
'It's going to be completely game-changing for a lot of women.'
We all know that hot flashes can be unbearable, but something about this medication just doesn't sit right.
Perhaps some of us are still wary of the what the medical community seems to be trying to push on us these days.
